Found 0 matching trials
Empagliflozin and Sympathetic Nerve Traffic PHASE4 In this study the effects of the Inhibition of the Sodium-Glucose Linked Tr...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes PHASE3 The objective of the study is to investigate the efficacy, safety and toler...
Show More Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin PHASE3 The purpose of the study is to demonstrate the superiority of sotagliflozin...
Show More Location
Investigational Site Number 8408035
Learn More & Join Trial
Impact of SGLT2 on Glucosuria in HNF1A-MODY NA Maturity onset diabetes of the young (MODY) is a subtype of diabetes which ...
Show More Location
Steno Diabetes Center Copenhagen
Learn More & Join Trial
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease PHASE2 Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes PHASE3 The purpose of this study is to assess safety and efficacy of empagliflozin...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention PHASE3 The aim of this randomized trial with a 2-by-2 factorial design is to test ...
Show More Location
University Hospital Amiens-Picardie
Learn More & Join Trial
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes PHASE2 This will be a placebo-controlled, randomized, double blind, crossover stud...
Show More Status
Active Not Recruiting
Location
University of Minnesota
Learn More & Join Trial
Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD) PHASE4 The EMPA-PKD trial is assessing the safety of empagliflozin in patients wit...
Show More Status
Active Not Recruiting
Location
Medizinische Hochschule Hannover
Learn More & Join Trial
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis PHASE4 1. This proposed double-blind placebo controlled randomized controlled tria...
Show More Location
PGIMER Chandigarh
Learn More & Join Trial